Nov 27 2019 0 American Depositary Shares (“ADS”) Program and Warrant Agent Agreement https://www.motifbio.com/wp-content/uploads/2019/11/MTFB-ADS-Program-Notification-27.11.19-1.pdf
Nov 26 2019 0 Motif Bio plc Announces Voluntary Delisting from the Nasdaq Capital Market https://www.motifbio.com/wp-content/uploads/2019/11/MTFB-Voluntary-Delisting-from-the-Nasdaq-Capital-Market-26.11.19.pdf
Nov 20 2019 0 Holding(s) in Company https://www.motifbio.com/wp-content/uploads/2019/11/Motif-Bio-Plc-notifications-major-interests-shares-tr1-15.11.2019-Company-002.pdf
Nov 18 2019 0 Directorate Changes https://www.motifbio.com/wp-content/uploads/2019/11/MTFB-Directorate-Changes-18.11.19.pdf
Nov 14 2019 0 Result of General Meeting https://www.motifbio.com/wp-content/uploads/2019/11/MTFB-Result-of-GM-RNS-14.11.19.pdf
Nov 11 2019 0 Settlement Agreement https://www.motifbio.com/wp-content/uploads/2019/11/MTFB-Settlement-Agreement-RNS-11.11.19.pdf
Oct 28 2019 0 Holding(s) in Company https://www.motifbio.com/wp-content/uploads/2019/10/MTFB-TR-1-Invesco-Ltd.-28.10.19.pdf
Oct 25 2019 0 Holding(s) in Company https://www.motifbio.com/wp-content/uploads/2019/10/MTFB-Invesco-TR-1-25.10.19.pdf
Oct 25 2019 0 Posting of Circular and Notice of General Meeting https://www.motifbio.com/wp-content/uploads/2019/10/MTFB-Posting-of-Circular-and-Notice-of-GM-25.10.19.pdf
Oct 24 2019 0 U.S. Army-funded research project to Evaluate Iclaprim https://www.motifbio.com/wp-content/uploads/2019/10/MTFB-DoD-RNS-24.10.19.pdf
